Back to Markets
LFLifeVantage Corp

LifeVantage Corp

LFVNNASDAQ NMS - GLOBAL MARKET
Health CareConsumer products

$7.87

+0.2000 (+2.61%)

As of 05/29/26 EDT · USD

Compare
Low: $3.90Current: $7.87High: $15.00

Key Statistics

Open

$7.94

Day High

$8.50

Day Low

$7.20

Prev. Close

$7.67

VolumeShares traded today.

425.00K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$99.29M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

17.63

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$15.00

52W LowLowest price over the past 52 weeks.

$3.90

50D MAAverage closing price over the last 50 trading days.

$5.04

200D MAAverage closing price over the last 200 trading days.

$7.06

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+46.6%

1M

+55.8%

6M

+16.2%

YTD

+30.5%

1Y

-39.7%

About

Protandim is a herbal dietary supplement marketed with unsupported claims that it can treat a number of medical conditions. The product is a patented mix of five herbal ingredients and sold by LifeVantage Corporation, a Utah-based multi-level marketing company. The manufacturers of Protandim make no claims that it can prevent or cure any medical conditions. In 2017, LifeVantage was issued a warning letter by the U.S. Food and Drug Administration (FDA) regarding illegal advertising claims on the company's websites suggesting that Protandim can help to cure various ailments, including cancer and diabetes.

www.lifevantage.com/

Company Facts

SectorHealth Care
IndustryConsumer products
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade LFVN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.